{"brief_title": "A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)", "brief_summary": "The purpose of this study is to determine the mumps virus strength at the end of shelf-life (expiration date) of an approved vaccine.", "condition": ["Measles", "Mumps", "Rubella", "Varicella"], "intervention_type": ["Biological", "Biological"], "intervention_name": ["Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live", "Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)"], "description": ["0.5 mL subcutaneous injection of one of three sub-lots on Day 0", "0.5 mL subcutaneous injection on Day 0"], "arm_group_label": ["Control Group", "Mumps Expiry Group 1", "Mumps Expiry Group 2", "Control Group", "Mumps Expiry Group 1", "Mumps Expiry Group 2"], "criteria": "Inclusion Criteria: - Healthy children 12 to 18 months of age Exclusion Criteria: - History or prior exposure to measles, mumps, rubella or varicella - History of anaphylactoid reactions or hypersensitivity to any component of the vaccine, including gelatin and neomycin", "gender": "All", "minimum_age": "12 Months", "maximum_age": "18 Months", "healthy_volunteers": "Accepts Healthy Volunteers", "mesh_term": ["Rubella", "Mumps", "Vaccines"], "id": "NCT00092391"}